Market Capitalization $7.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
|
|
- Barnard Woods
- 6 years ago
- Views:
Transcription
1 BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BIO BUSINESS DESCRIPTION Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. STOCK PERFORMANCE (%) 3 Mo. 1 Yr. 3 Yr (Ann) Price Change GROWTH (%) Last Qtr 12 Mo. 3 Yr CAGR Revenues Net Income EPS RETURN ON EQUITY (%) BIO Ind Avg S&P 500 Q Q Q BUY Sector: Health Care Sub-Industry: Life Sciences Tools & Services Source: S&P BUY RATING SINCE 11/14/2017 TARGET PRICE $ Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years COMPUSTAT for Price and Volume, TheStreet Ratings, Inc. for Rating History TARGET PRICE $ Rating History BUY BUY HOLD Volume in Millions P/E COMPARISON RECOMMENDATION We rate (BIO) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any nesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity BIO Ind Avg S&P 500 HIGHLIGHTS The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Life Sciences Tools & Services industry. The net income increased by 48.8% when compared to the same quarter one year prior, rising from $18.41 million to $27.39 million. EPS ALYSIS¹ ($) Q Q Q Q Q Q Q Q Q Q Q Despite its growing revenue, the company underperformed as compared with the industry average of 11.4%. Since the same quarter one year prior, revenues slightly increased by 5.2%. Growth in the company's revenue appears to have helped boost the earnings per share. BIO's debt-to-equity ratio is very low at 0.15 and is currently below that of the industry average, implying that there has been very successful management of debt levels. To add to this, BIO has a quick ratio of 2.45, which demonstrates the ability of the company to cover short-term liquidity needs The gross profit margin for is rather high; currently it is at 63.53%. It has increased from the same quarter the previous year. Regardless of the results of the gross profit margin, the net profit margin of 5.12% trails the industry average. = not available NM = not meaningful 1 Compustat fiscal year convention is used for all fundamental data items. Powered by its earnings growth of 46.77% and other important driving factors, this stock has surged by 48.91% over the past year, outperforming the rise in the S&P 500 Index during the same period. We feel that the stock's sharp appreciation over the last year has driven it to a price level which is now somewhat expensive compared to the rest of its industry. The other strengths this company shows, however, justify the higher price levels. Report Date: PAGE 1
2 PEER GROUP ALYSIS REVENUE GROWTH AND EBITDA MARGIN* Revenue Growth (TTM) 0% 60% UNFAVORABLE PRAH IQV ICLR BRKR 14% BIO.B PKI EBITDA Margin (TTM) A MTD FAVORABLE QGEN WAT 34% Companies with higher EBITDA margins and revenue growth rates are outperforming companies with lower EBITDA margins and revenue growth rates. Companies for this scatter plot have a market capitalization between $5.1 Billion and $22.1 Billion. Companies with or NM values do not appear. *EBITDA Earnings Before Interest, Taxes, Depreciation and Amortization. REVENUE GROWTH AND EARNINGS YIELD Revenue Growth (TTM) 0% 60% IQV UNFAVORABLE QGEN 0% BIO.B Earnings Yield (TTM) PRAH MTD BRKR A FAVORABLE WAT ICLR PKI 4.5% Companies that exhibit both a high earnings yield and high revenue growth are generally more attractive than companies with low revenue growth and low earnings yield. Companies for this scatter plot have revenue growth rates between 2.1% and 56.7%. Companies with or NM values do not appear. INDUSTRY ALYSIS The life sciences tools and services (LSTS) industry is comprised of biotechnology companies and health care services, supplies, and equipment companies. The industry also includes firms that provide analytical tools, instruments, consumables and supplies, clinical trial services, contract research services, and technology solutions. The industry is complex and categorized into eight segments: genomics, proteomics, cell biology, combinatorial chemistry, small-animal in vivo analysis, bioinformatics, and general labware. Major LSTS players are Thermo Fisher Scientific (TMO), Agilent Technologies (A), Waters (WAT), and Illumina (ILMN). The industry has been historically fragmented, but recently, companies seeking expanded R&D capabilities or economies of scale have sought consolidation and collaboration. Genomics research progressed in the late 1990s and the early 2000s saw the emergence of proteomics. Currently, research and development is directed towards cell biology and animal in vivo research, which help to develop safer drugs by providing improved late-stage screening. More than 20% of the US population will be 65 years or older by 2050, implying increased demand for heart disease, diabetes, and cancer drugs. This scenario prompts LSTS companies to develop new therapies as well as new enzymes, chemical sensors, diagnostics and nanotechnology. The discovery of substitute drugs and stringent Food and Drug Administration (FDA) regulations are entrenched problems. Failure to meet FDA regulations leads to delays in product approval, penalties, plant closures, and loss of revenue. After the enactment of the Food and Drug Administration Modernization Act of 1997, the FDA tightened the approval procedure. Despite rising costs and shrinking margins, industry outlook remains positive due to technology advances, robust product pipeline, and sophisticated research. As the US baby boomer population ages, healthcare spending is projected to keep growing. PEER GROUP: Life Sciences Tools & Services Recent Market Price/ Net Sales Net Income Ticker Company Name Price ($) Cap ($M) Earnings TTM ($M) TTM ($M) BIO , , PKI PERKINELMER INC , , BIO.B , , QGEN QIAGEN NV , , ICLR ICON PLC , , BRKR BRUKER CORP , , PRAH PRA HEALTH SCIENCES INC , , A AGILENT TECHNOLOGIES INC , , IQV IQVIA HOLDINGS INC , , MTD METTLER-TOLEDO INTL INC , , WAT WATERS CORP , , The peer group comparison is based on Major Life Sciences Tools & Services companies of comparable size. Report Date: PAGE 2
3 Annual Dividend Rate COMPANY DESCRIPTION Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California Alfred Nobel Drive Hercules, CA USA Phone: Fax: STOCK-AT-A-GLANCE Below is a summary of the major fundamental and technical factors we consider when determining our overall recommendation of BIO shares. It is provided in order to give you a deeper understanding of our rating methodology as well as to paint a more complete picture of a stock's strengths and nesses. It is important to note, however, that these factors only tell part of the story. To gain an even more comprehensive understanding of our stance on the stock, these factors must be assessed in combination with the stock s valuation. Please refer to our Valuation section on page 5 for further information. FACTOR SCORE Growth 1.5 out of 5 stars Measures the growth of both the company's income statement and cash flow. On this factor, BIO has a growth score better than 20% of the stocks we rate. Total Return 5.0 out of 5 stars Measures the historical price movement of the stock. The stock performance of this company has beaten 90% of the companies we cover. Efficiency 2.5 out of 5 stars Measures the strength and historic growth of a company's return on invested capital. The company has generated more income per dollar of capital than 40% of the companies we review. Price volatility 5.0 out of 5 stars Measures the volatility of the company's stock price historically. The stock is less volatile than 90% of the stocks we monitor. Solvency 4.5 out of 5 stars Measures the solvency of the company based on several ratios. The company is more solvent than 80% of the companies we analyze. Income 0.5 out of 5 stars Measures dividend yield and payouts to shareholders. This company pays no dividends. THESTREET RATINGS RESEARCH METHODOLOGY TheStreet Ratings' stock model projects a stock's total return potential over a 12-month period including both price appreciation and dividends. Our Buy, Hold or Sell ratings designate how we expect these stocks to perform against a general benchmark of the equities market and interest rates. While our model is quantitative, it utilizes both subjective and objective elements. For instance, subjective elements include expected equities market returns, future interest rates, implied industry outlook and forecasted company earnings. Objective elements include volatility of past operating revenues, financial strength, and company cash flows. Our model gauges the relationship between risk and reward in several ways, including: the pricing drawdown as compared to potential profit volatility, i.e.how much one is willing to risk in order to earn profits; the level of acceptable volatility for highly performing stocks; the current valuation as compared to projected earnings growth; and the financial strength of the underlying company as compared to its stock's valuation as compared to projected earnings growth; and the financial strength of the underlying company as compared to its stock's performance. These and many more derived observations are then combined, ranked, weighted, and scenario-tested to create a more complete analysis. The result is a systematic and disciplined method of selecting stocks. Report Date: PAGE 3
4 Consensus EPS Estimates² ($) IBES consensus estimates are provided by Thomson Financial FINCIAL ALYSIS 's gross profit margin for the third quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company has grown its sales and net income during the past quarter when compared with the same quarter a year ago, and although its growth in net income has outpaced the industry average, its revenue growth has not. is extremely liquid. Currently, the Quick Ratio is 2.45 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow Q4 FY E 2017(E) 4.96 E 2018(E) During the same period, stockholders' equity ("net worth") has increased by 5.39% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future. INCOME STATEMENT Net Sales ($mil) EBITDA ($mil) EBIT ($mil) Net Income ($mil) STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit BALANCE SHEET Cash & Equiv. ($mil) Total Assets ($mil) 4, , Total Debt ($mil) Equity ($mil) 2, , PROFITABILITY Gross Profit Margin 63.53% 62.56% EBITDA Margin 16.84% 12.99% Operating Margin 10.24% 5.43% Sales Turnover Return on Assets 0.57% 2.44% Return on Equity 0.85% 3.63% DEBT Current Ratio Debt/Capital Interest Expense Interest Coverage SHARE DATA Shares outstanding (mil) Div / share EPS Book value / share Institutional Own % Avg Daily Volume 178, ,988 2 Sum of quarterly figures may not match annual estimates due to use of median consensus estimates. Report Date: PAGE 4
5 RATINGS HISTORY Our rating for was recently upgraded from Hold to Buy on 11/14/2017. As of 11/16/2017, the stock was trading at a price of which is 4.5% below its 52-week high of $ and 51.5% above its 52-week low of $ VALUATION BUY. 's P/E ratio indicates a significant premium compared to an average of for the Life Sciences Tools & Services industry and a significant premium compared to the S&P 500 average of To use another comparison, its price-to-book ratio of 2.68 indicates a discount versus the S&P 500 average of 3.16 and a significant discount versus the industry average of The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. 2 Year Chart BUY: $ BUY: $ BUY: $ HOLD: $ $300 $250 $200 $150 MOST RECENT RATINGS CHANGES Date Price Action From To 11/14/17 $ Upgrade Hold Buy 8/4/17 $ Downgrade Buy Hold 3/8/16 $ Upgrade Hold Buy 1/29/16 $ Downgrade Buy Hold 11/16/15 $ No Change Buy Buy Price reflects the closing price as of the date listed, if available RATINGS DEFINITIONS & DISTRIBUTION OF THESTREET RATINGS (as of 11/16/2017) 43.95% Buy - We believe that this stock has the opportunity to appreciate and produce a total return of more than 10% over the next 12 months % Hold - We do not believe this stock offers conclusive evidence to warrant the purchase or sale of shares at this time and that its likelihood of positive total return is roughly in balance with the risk of loss. Price/Earnings BIO Peers Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations. Price/Projected Earnings BIO Peers Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations. Price/Book BIO 2.68 Peers 6.39 Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. BIO is trading at a significant discount to its peers. Price/Sales BIO 3.61 Peers 9.00 Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. BIO is trading at a significant discount to its industry on this measurement. Price/CashFlow BIO Peers Premium. The P/CF ratio, a stock s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. Price to Earnings/Growth BIO 1.78 Peers 0.92 Premium. The PEG ratio is the stock s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. BIO trades at a significant premium to its peers. Earnings Growth lower higher BIO Peers 7.68 Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, BIO is expected to significantly trail its peers on the basis of its earnings growth rate. Sales Growth lower higher BIO 2.12 Peers Lower. A sales growth rate that trails the industry implies that a company is losing market share. BIO significantly trails its peers on the basis of sales growth 25.29% Sell - We believe that this stock is likely to decline by more than 10% over the next 12 months, with the risk involved too great to compensate for any possible returns. TheStreet Ratings 14 Wall Street, 15th Floor New York, NY Research Contact: Sales Contact: DISCLAIMER: The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but TheStreet Ratings cannot guarantee its accuracy and completeness, and that of the opinions based thereon. Data is provided via the COMPUSTAT Xpressfeed product from Standard &Poor's, a division of The McGraw-Hill Companies, Inc., as well as other third-party data providers. TheStreet Ratings is a division of TheStreet, Inc., which is a publisher. This research report contains opinions and is provided for informational purposes only. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional, before you make any investment. None of the information contained in this report constitutes, or is intended to constitute a recommendation by TheStreet Ratings of any particular security or trading strategy or a determination by TheStreet Ratings that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Your use of this report is governed by TheStreet, Inc.'s Terms of Use found at Report Date: PAGE 5
Market Capitalization $6.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY SDAQ: ICLR BUY RATING SINCE 03/26/2013 TARGET PRICE $151.83 ICLR BUSINESS DESCRIPTION ICON Public Limited Company, a contract
More informationMarket Capitalization $3.2 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 08/15/2017 TARGET PRICE $33.32 BUSINESS DESCRIPTION Stantec Inc. provides professional consulting services
More informationMarket Capitalization $727.4 Million
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 12/16/2010 TARGET PRICE $51.40 BUSINESS DESCRIPTION Middlesex Water Company, through its subsidiaries,
More informationMarket Capitalization $5.4 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years BUY HOLD BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate OHI BUSINESS DESCRIPTION Omega is a real estate investment trust investing in and providing financing to the long-term care
More informationMarket Capitalization $4.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 04/08/2011 TARGET PRICE $180.12 BUSINESS DESCRIPTION Fair Isaac Corporation develops analytic, software,
More informationMarket Capitalization $21.8 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 12/07/2010 TARGET PRICE $85.63 BUSINESS DESCRIPTION Republic Services, Inc., together with its subsidiaries,
More informationMarket Capitalization $4.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY November 26, 2017 BUY RATING SINCE 08/05/2016 TARGET PRICE $36.47 BUSINESS DESCRIPTION Rayonier is a leading timberland real estate investment
More informationMarket Capitalization $116.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide.
More informationMarket Capitalization $12.8 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 11/21/2017 BUSINESS DESCRIPTION Nielsen Holdings plc operates as an information and measurement company.
More informationMarket Capitalization $371.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION organ Chase & Co. operates as a financial services company worldwide. It operates through Consumer & Community
More informationMarket Capitalization $1.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION is a real estate investment trust, or REIT, which primarily owns properties located throughout the United
More informationMarket Capitalization $11.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 01/17/2013 TARGET PRICE $168.92 BUSINESS DESCRIPTION Inc., together with its subsidiaries, provides products
More informationMarket Capitalization $1.7 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 01/17/2013 TARGET PRICE $59.66 BUSINESS DESCRIPTION Ameris Bancorp operates as the holding company for
More informationMarket Capitalization $2.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 06/12/2012 BUSINESS DESCRIPTION No company description available. STOCK PERFORMANCE (%) 3 Mo. 1 Yr. 3
More informationMarket Capitalization $2.0 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 11/02/2016 BUSINESS DESCRIPTION Pitney Bowes Inc. offers customer information management, location intelligence,
More informationMarket Capitalization $7.4 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY December 31, 2017 BUY RATING SINCE 05/06/2016 TARGET PRICE $80.00 WPC BUSINESS DESCRIPTION W. P. Carey Inc. is a leading internally-managed net
More informationMarket Capitalization $11.5 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance brokerage and risk management
More informationMarket Capitalization $16.7 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY December 3, 2017 BUY RATING SINCE 11/30/2010 TARGET PRICE $188.87 BUSINESS DESCRIPTION Cintas Corporation provides corporate identity uniforms
More informationMarket Capitalization $1.5 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 02/07/2012 TARGET PRICE $51.84 BUSINESS DESCRIPTION CSG Systems International, Inc. provides business support
More informationMarket Capitalization $294.8 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 12/23/2011 TARGET PRICE $65.22 BUSINESS DESCRIPTION Wells Fargo & Company, a diversified financial services
More informationMarket Capitalization $75.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 11/19/2015 BUSINESS DESCRIPTION Salesforce.com, inc. develops enterprise cloud computing solutions with
More informationMarket Capitalization $39.0 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate SELL SELL RATING SINCE 04/18/2013 BUSINESS DESCRIPTION Deutsche Bank Aktiengesellschaft provides investment, financial, and
More informationMarket Capitalization $3.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Aspen Insurance Holdings Limited, through its subsidiaries, engages in insurance and reinsurance businesses
More informationMarket Capitalization $6.5 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Endurance Specialty Holdings Ltd., through its subsidiaries, underwrites specialty lines of personal and
More informationMarket Capitalization $480.3 Million
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY November 12, 2017 BUY RATING SINCE 12/16/2016 TARGET PRICE $21.59 BUSINESS DESCRIPTION XO Group Inc. provides multiplatform media and marketplace
More informationMarket Capitalization $11.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Fidelity National Financial, Inc., together with its subsidiaries, provides title insurance, and technology
More informationMarket Capitalization $11.9 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Cincinnati Financial Corporation engages in the property casualty insurance business in the United States.
More informationMarket Capitalization $13.1 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Martin Marietta Materials, Inc., together with its subsidiaries, supplies aggregates products and heavy
More informationMarket Capitalization $209.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F $ BUY December 3, 2017 BUY RATING SINCE 11/30/2010 TARGET PRICE $51.79 BUSINESS DESCRIPTION Intel Corporation designs, manufactures, and sells computer,
More informationMarket Capitalization $4.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 03/13/2017 TARGET PRICE $171.47 BUSINESS DESCRIPTION Visteon Corporation designs, engineers, and manufactures
More informationMarket Capitalization $153.0 Billion BUY HOLD BUY HOLD
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 05/18/2017 BUSINESS DESCRIPTION General Electric Company operates as an infrastructure and technology
More informationMarket Capitalization $69.4 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Lowe's Companies, Inc. operates as a home improvement company in the United States, Canada, and Mexico.
More informationMarket Capitalization $477.5 Million
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY SDAQ: BUY RATING SINCE 09/13/2016 TARGET PRICE $49.86 BUSINESS DESCRIPTION Blue Nile, Inc. operates as an online retailer
More informationMarket Capitalization $11.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 08/09/2016 CX BUSINESS DESCRIPTION CEMEX, S.A.B. de C.V., together with its subsidiaries, produces, markets,
More informationMarket Capitalization $3.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of R-based
More informationMarket Capitalization $3.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Ollie's Bargain Outlet Holdings, Inc. operates as a retailer of brand name merchandise. STOCK PERFORMANCE
More informationMarket Capitalization $517.2 Million
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate SDAQ: HOLD HOLD RATING SINCE 11/12/2015 BUSINESS DESCRIPTION Energy Recovery, Inc. provides energy solutions to industrial fluid
More informationMarket Capitalization $507.9 Million
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate $ BUY SDAQ: WI BUY RATING SINCE 11/30/2010 TARGET PRICE $174.43 WI BUSINESS DESCRIPTION Winmark Corporation operates as a franchisor
More informationMarket Capitalization $101.1 Billion. Sector: Industrials Sub-Industry: Railroads Source: S&P Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F December 10, 2017 BUY BUY RATING SINCE 12/07/2010 TARGET PRICE $148.37 BUSINESS DESCRIPTION Union Pacific Corporation, through its subsidiary, Union
More informationMarket Capitalization $24.2 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. It provides
More informationMarket Capitalization $69.7 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through
More informationMarket Capitalization $27.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Royal Caribbean Cruises Ltd. operates as a cruise company. The company operates cruises under the Royal
More informationMarket Capitalization $94.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Reynolds American Inc., through its subsidiaries, manufactures, and sells cigarettes and other tobacco
More informationMarket Capitalization $11.8 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Etablissements Delhaize Freres et Cie `Le Lion' (Groupe Delhaize) Societe Anonyme, together with its subsidiaries,
More informationMarket Capitalization $11.2 Billion SELL HOLD SELL HOLD
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 3, 2017 HOLD RATING SINCE 02/21/2017 BUSINESS DESCRIPTION Goldcorp Inc. acquires, explores for, develops, and operates precious metal
More informationMarket Capitalization $20.4 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate SDAQ: BUY BUY RATING SINCE 07/19/2013 TARGET PRICE $334.58 BUSINESS DESCRIPTION Align Technology, Inc. designs, manufactures,
More informationMarket Capitalization $20.1 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Magna International Inc. designs, develops, and manufactures automotive systems, assemblies, modules, and components
More informationMarket Capitalization $10.5 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. STOCK PERFORMANCE (%) 3 Mo.
More informationMarket Capitalization $175.0 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY December 17, 2017 BUY RATING SINCE 07/27/2017 TARGET PRICE $385.72 BUSINESS DESCRIPTION The Boeing Company, together with its subsidiaries, designs,
More informationMarket Capitalization $205.7 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Verizon Communications Inc., through its subsidiaries, provides communications, information, and entertainment
More informationMarket Capitalization $90.3 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development,
More informationMarket Capitalization $30.1 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION The Progressive Corporation, through its subsidiaries, provides personal and commercial property-casualty
More informationMarket Capitalization $4.8 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Grupo Aeroportuario del Sureste, S. A. B. de C. V. holds concessions to operate, maintain, and develop
More informationMarket Capitalization $38.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY December 24, 2017 BUY RATING SINCE 12/21/2010 TARGET PRICE $155.60 BUSINESS DESCRIPTION Ecolab Inc. provides water, hygiene, and energy technologies
More informationMarket Capitalization $8.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years HOLD BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUSINESS DESCRIPTION Randgold Resources Limited explores for and develops gold deposits in Sub-Saharan Africa. STOCK PERFORMANCE (%) 3 Mo. 1 Yr.
More informationMarket Capitalization $12.9 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years HOLD BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION CenterPoint Energy, Inc. operates as a public utility holding company in the United States. STOCK PERFORMANCE
More informationMarket Capitalization $2.2 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate SDAQ: HOLD HOLD RATING SINCE 09/27/2016 BUSINESS DESCRIPTION Cal-Maine Foods, Inc. produces, grades, packages, markets, and
More informationMarket Capitalization $204.2 Billion
BUY HOLD SELL A+ A A- B+ B B- + - D+ D D- E+ E E- F BUY December 17, 2017 BUY RATING SINE 08/24/2016 TARGET PRIE $97.02 BUSINESS DESRIPTION itigroup Inc., a diversified financial services holding company,
More informationMarket Capitalization $27.0 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 10, 2017 HOLD RATING SINCE 05/16/2016 BUSINESS DESCRIPTION Nokia Corporation, together with its subsidiaries, provides network infrastructure
More informationMarket Capitalization $23.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 10, 2017 HOLD RATING SINCE 06/16/2017 BUSINESS DESCRIPTION The Kroger Co., together with its subsidiaries, operates as a retailer in
More informationMarket Capitalization $884.7 Million. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Frontier Communications Corporation provides communications services to residential, business, and wholesale
More informationMarket Capitalization $2.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY November 19, 2017 CIE CORP BUY RATING SINCE 06/20/2017 TARGET PRICE $23.61 BUSINESS DESCRIPTION Ciena Corporation provides equipment, software,
More informationMarket Capitalization $3.0 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. STOCK PERFORMANCE
More informationMarket Capitalization $4.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Columbia Sportswear Company designs, sources, markets, and distributes outdoor and active lifestyle apparel,
More informationMarket Capitalization $5.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate SELL SELL RATING SINCE 04/25/2017 BUSINESS DESCRIPTION Under Armour, Inc., together with its subsidiaries, develops, markets,
More informationMarket Capitalization $195.1 Billion BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 10, 2017 HOLD RATING SINCE 12/01/2017 BUSINESS DESCRIPTION The Coca-Cola Company, a beverage company, manufactures and distributes
More informationMarket Capitalization $2.4 Billion. Sector: Health Care Sub-Industry: Biotechnology Source: S&P Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F December 3, 2017 SDAQ: HOLD HOLD RATING SINCE 03/02/2017 BUSINESS DESCRIPTION Myriad Genetics, Inc., a molecular diagnostic company, focuses on developing
More informationMarket Capitalization $1.5 Billion. Sector: Materials Sub-Industry: Silver Source: S&P Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 3, 2017 HOLD RATING SINCE 08/04/2017 BUSINESS DESCRIPTION Hecla Mining Company, together with its subsidiaries, discovers, acquires,
More informationMarket Capitalization $167.0 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 12/14/2010 TARGET PRICE $127.71 BUSINESS DESCRIPTION The Walt Disney Company, together with its subsidiaries,
More informationMarket Capitalization $37.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 09/28/2004 TARGET PRICE $45.29 BUSINESS DESCRIPTION Provides chemical, plastic and agricultural products
More informationMarket Capitalization $19.7 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUSINESS DESCRIPTION Freeport-McMoRan Inc. engages in the mining of mineral properties in the United States, Indonesia, Peru, and Chile. It primarily
More informationMarket Capitalization $9.7 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 11/22/2010 TARGET PRICE $155.94 BUSINESS DESCRIPTION Ingredion Incorporated, together with its subsidiaries,
More informationMarket Capitalization $9.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 03/08/2013 TARGET PRICE $295.52 BUSINESS DESCRIPTION Vail Resorts, Inc., through its subsidiaries, operates
More informationMarket Capitalization $32.8 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years HOLD BUY HOLD BUY
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUSINESS DESCRIPTION Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Peru, Mexico,
More informationMarket Capitalization $439.8 Million. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION BP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. The company holds overriding
More informationMarket Capitalization $5.8 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION EQT Midstream Partners, LP provides natural gas transmission, storage, and gathering services in Pennsylvania,
More informationMarket Capitalization $99.1 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate HOLD HOLD RATING SINCE 09/20/2017 BUSINESS DESCRIPTION The Kraft Heinz Company manufactures and markets food and beverage products
More informationMarket Capitalization $11.5 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 08/10/2016 TARGET PRICE $47.14 BUSINESS DESCRIPTION Coach, Inc. provides luxury accessories and lifestyle
More informationMarket Capitalization $16.6 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 10/29/2015 TARGET PRICE $128.12 BUSINESS DESCRIPTION The Hershey Company, together with its subsidiaries,
More informationMarket Capitalization $374.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 03/30/2012 TARGET PRICE $161.28 BUSINESS DESCRIPTION Johnson & Johnson, together with its subsidiaries,
More informationMarket Capitalization $10.5 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Targa Resources Corp., through its general and limited partner interests in Targa Resources Partners LP,
More informationMarket Capitalization $64.3 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate PBR BUSINESS DESCRIPTION Petroleo Brasileiro S.A. - Petrobras operates in the oil, natural gas, and energy industries. STOCK
More informationMarket Capitalization $228.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 11/20/2015 TARGET PRICE $103.94 BUSINESS DESCRIPTION The Procter & Gamble Company provides branded consumer
More informationMarket Capitalization $7.8 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Harman International Industries, Incorporated designs and engineers connected products and solutions for
More informationMarket Capitalization $97.8 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F HOLD December 17, 2017 HOLD RATING SINCE 11/10/2017 ABEV BUSINESS DESCRIPTION Ambev S.A., through its subsidiaries, produces, distributes, and sells
More informationMarket Capitalization $305.2 Million. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets in the United States
More informationMarket Capitalization $14.9 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Magellan Midstream Partners, L.P. engages in the transportation, storage, and distribution of refined petroleum
More informationMarket Capitalization $47.3 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY November 19, 2017 BUY RATING SINCE 07/03/2017 TARGET PRICE $106.79 BUSINESS DESCRIPTION Phillips 66 operates as an energy manufacturing and logistics
More informationMarket Capitalization $1.6 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Teekay LNG Partners L.P. provides marine transportation services for liquefied natural gas (LNG), liquefied
More informationMarket Capitalization $38.3 Billion
HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate RATING SINCE 11/15/2016 TARGET PRICE $114.82 BUSINESS DESCRIPTION Valero Energy Corporation operates as an independent petroleum
More informationMarket Capitalization $123.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY December 10, 2017 BUY RATING SINCE 11/09/2017 TARGET PRICE $45.40 BUSINESS DESCRIPTION p.l.c. operates as an integrated oil and gas company worldwide.
More informationMarket Capitalization $31.9 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUY BUY RATING SINCE 12/14/2010 TARGET PRICE $64.83 BUSINESS DESCRIPTION General Mills, Inc. manufactures and markets branded
More informationMarket Capitalization $15.7 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F Annual Dividend Rate BUSINESS DESCRIPTION Molson Coors Brewing Company manufactures and sells beer and other beverage products in the United States,
More informationMarket Capitalization $112.8 Billion
BUY HOLD SELL A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F BUY November 19, 2017 BUY RATING SINCE 04/25/2017 TARGET PRICE $56.90 SNY BUSINESS DESCRIPTION Sanofi researches, develops, manufactures, and markets
More informationSUMMARY A 543 A 524 A 593 A 2,166 A A 556 A 542 A 608 A 2,237 A E 569 E 562 E 636 E 2,306 E ,424 E
February 03, 2015 PerkinElmer Inc. Current Recommendation Prior Recommendation NEUTRAL Underperform Date of Last Change 09/18/2013 Current Price (02/02/15) $45.59 Target Price $48.00 SUMMARY (PKI-NYSE)
More informationEquity Research. Life Science Tools Q1 Preview. April 8, 2016
April 8, 2016 Equity Research Life Science Tools Q1 Preview Sector Rating: Life Science Tools, Market Weight FY EPS Valuation Range Rating Price 2016 2017 Ticker Curr. Prior 04/08/16 Curr. Prior Curr.
More informationTrailing PE -- Forward PE Buy 6 Analysts. 1-Year Return: -5.7% 5-Year Return: 710.7%
ING GROUP (-AE) Last Close 0.95 (EUR) Avg Daily Vol 11.9M 52-Week High 1.62 Trailing PE -- Annual Div -- ROE -112.3% LTG Forecast -- 1-Mo 1.9% November 01 AMSTERDAM Exchange Market Cap 551M 52-Week Low
More informationNavigant Consulting Inc.
February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00
More informationTrailing PE Forward PE Buy 7 Analysts. 1-Year Return: 5.1% 5-Year Return: 99.8%
OPEN TEXT CORP (-T) Last Close 44.09 (CAD) Avg Daily Vol 697,695 52-Week High 51.98 Trailing PE 37.1 Annual Div 0.81 ROE 6.7% LTG Forecast 11.4% 1-Mo -2.0% November 22 TORONTO Exchange Market Cap 11.7B
More informationTrailing PE Forward PE Buy 3 Analysts. 1-Year Return: -35.3% 5-Year Return: 339.3%
TON CONTROL INC (-T) Last Close 1.34 (CAD) Avg Daily Vol 169,152 52-Week High 2.60 Trailing PE 16.8 Annual Div -- ROE 21.7% LTG Forecast -- 1-Mo 55.8% 2019 January 25 TORONTO Exchange Market Cap 147M 52-Week
More information